You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Imiquimod

Showing 26 - 50 of 214
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Actinic Keratosis Trial in Nice (Aldara (Imiquimod), Vehicle cream)

Completed
  • Actinic Keratosis
  • Aldara (Imiquimod)
  • Vehicle cream
  • Nice, Cedex 3, France
    Hopital L'Archet 2
Feb 4, 2022

Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Radiation
  • +2 more
  • New York, New York
    New York University Medical Center
Oct 25, 2021

Genital Warts Trial in Italy (Imiquimod, vehicle cream)

Completed
  • Genital Warts
  • Imiquimod
  • vehicle cream
  • Ancona, Italy
  • +11 more
Feb 4, 2022

Recurrence Rates of Actinic Keratoses One Year After Completion

Completed
  • Actinic Keratoses
  • Imiquimod
  • (no location specified)
Feb 4, 2022

Intraepithelial Neoplasia, Cervical Trial in Maribor (Aldara 5% Topical Cream, LLETZ)

Active, not recruiting
  • Intraepithelial Neoplasia, Cervical
  • Aldara 5% Topical Cream
  • LLETZ
  • Maribor, Slovenia
    University Medical Centre Maribor
Apr 28, 2021

Warts Trial in Belgium, France (Imiquimod 5% cream)

Completed
  • Warts
  • Imiquimod 5% cream
  • Brussels, Belgium
  • +17 more
Feb 4, 2022

Basal Cell Carcinoma Trial in Providence (5% Imiquimod cream, Placebo Vehicle Control Cream)

Not yet recruiting
  • Basal Cell Carcinoma
  • 5% Imiquimod cream
  • Placebo Vehicle Control Cream
  • Providence, Rhode Island
    Providence VA Medical Center, Providence, RI
Jan 14, 2022

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

Completed
  • Malignant Glioma
  • +3 more
  • Dendritic Cell Vaccine
  • +3 more
  • Miami, Florida
    University of Miami
Jul 19, 2022

Bladder Cancer, Bladder Trial in Houston (UGN-201)

Recruiting
  • Bladder Cancer
  • Bladder
  • Houston, Texas
    M D Anderson Cancer Center
Jul 11, 2022

Mycosis Fungoides Trial (3.75% Imiquimod Cream, 0.1% Fluocinonide Cream)

Withdrawn
  • Mycosis Fungoides
  • 3.75% Imiquimod Cream
  • 0.1% Fluocinonide Cream
  • (no location specified)
Apr 23, 2021

Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

Completed
  • Leukemia, Chronic Lymphatic
  • Peptide Vaccine
  • Imiquimod
  • Stuttgart, Baden-Wuerttemberg, Germany
  • +4 more
Nov 24, 2022

Influenza Trial in Hong Kong (Vaxigrip tetra, Fluzone high-dose, Aldara 5% Topical Cream)

Recruiting
  • Influenza
  • Vaxigrip tetra
  • +3 more
  • Hong Kong, Hong Kong
    University of Hong Kong, Queen Mary Hospital
Apr 27, 2021

Vulvar Intraepithelial Neoplasia Trial in Austria (Imiquimod, Surgery)

Completed
  • Vulvar Intraepithelial Neoplasia
  • Imiquimod
  • Surgery
  • Linz, Oberösterreich, Austria
  • +8 more
Apr 13, 2021

Actinic Keratosis Trial in Austria, Germany (Imiquimod, Diclofenac)

Completed
  • Actinic Keratosis
  • Graz, Austria
  • +16 more
Feb 4, 2022

Actinic Keratosis Trial in New York (Imiquimod 3.75% Cream)

Completed
Has Results
  • Actinic Keratosis
  • Imiquimod 3.75% Cream
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 30, 2020

Keloid Trial in Philadelphia (Imiquimod 5% cream)

Terminated
Has Results
  • Keloid
  • Imiquimod 5% cream
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 16, 2020

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN) Trial in

Completed
  • Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
  • +6 more
  • VGX-3100
  • +2 more
  • Newark, Delaware
  • +14 more
Dec 6, 2021

High Grade Intraepithelial Neoplasia, Cervix Cancer Trial in Barretos (Control, Imiquimod)

Completed
  • High Grade Intraepithelial Neoplasia
  • Cervix Cancer
  • Control
  • Imiquimod
  • Barretos, Brazil
    Barretos Cancer Hospital
Feb 15, 2021

Malignant Melanoma Trial in New York (Imiquimod, NY-ESO-1 protein)

Completed
Has Results
  • Malignant Melanoma
  • Imiquimod
  • NY-ESO-1 protein
  • New York, New York
    NYU Cancer Institute
Sep 28, 2020

Itch Trial in Aalborg (Zyclara 3.75 % Topical Cream, Prudoxin, Histamine)

Withdrawn
  • Itch
  • Zyclara 3.75 % Topical Cream
  • +5 more
  • Aalborg, Nordjylland, Denmark
    Aalborg University
Jan 13, 2021

Anogenital Human Papillomavirus Infection, Condyloma Anal Trial in Innsbruck (Imiquimod 5% cream, Placebo cream, Fulguration)

Not yet recruiting
  • Anogenital Human Papillomavirus Infection
  • Condyloma Anal
  • Imiquimod 5% cream
  • +2 more
  • Innsbruck, Tyrol, Austria
    Visceral-, Transplant- and Thoracic Surgery
Sep 22, 2020

Actinic Keratosis Trial in United States (Imiquimod Cream, 3.75%, Zyclara®, Vehicle of Test Product)

Completed
Has Results
  • Actinic Keratosis
  • Imiquimod Cream, 3.75%
  • +2 more
  • Tucson, Arizona
  • +22 more
Nov 6, 2020

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Actinic Keratosis Trial in Austria, France, Germany (Imiquimod, Diclofenac)

Completed
  • Actinic Keratosis
  • Feldkirch, Austria
  • +25 more
Feb 4, 2022

Newly Diagnosed H3-mutated Glioma Trial in Germany (drug, biological, other)

Recruiting
  • Newly Diagnosed H3-mutated Glioma
  • Tecentriq 1200 MG in 20 ML Injection
  • +2 more
  • Mannheim, Baden-Wuerttemberg, Germany
  • +7 more
Jan 18, 2023